Global Antacids Market to Cross ~USD 9 Billion Mark by 2030 | DelveInsight
November 21, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Global Antacids Market to Cross ~USD 9 Billion Mark by 2030 | DelveInsight The rising need for antacids is primarily driven by key factors such as...
Hidradenitis Suppurativa Market to Showcase Remarkable Growth at a CAGR of 12.4% by 2034 | DelveInsight
November 20, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Hidradenitis Suppurativa Market to Showcase Remarkable Growth at a CAGR of 12.4% by 2034 | DelveInsight According to DelveInsight’s analysis, the...
Advancing Stargardt Disease Treatments: 20+ Companies Poised to Accelerate the Therapeutic Pipeline | DelveInsight
November 19, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Advancing Stargardt Disease Treatments: 20+ Companies Poised to Accelerate the Therapeutic Pipeline | DelveInsight Advancements in gene therapy is a...
Human Papillomavirus Market is Projected to Boost at a Moderate Growth Rate During the Study Period (2020–2034) | DelveInsight
November 18, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Human Papillomavirus Market is Projected to Boost at a Moderate Growth Rate During the Study Period (2020–2034) | DelveInsight According to...
Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight
November 14, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight The demand for organoids is being driven mainly by an...
NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight
November 13, 2024 12:30 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment |...
Non-Cystic Fibrosis Bronchiectasis Pipeline Insight: Over 15 Companies are Progressing Through to Improve the Treatment Landscape | DelveInsight
November 13, 2024 10:30 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Non-Cystic Fibrosis Bronchiectasis Pipeline Insight: Over 15 Companies are Progressing Through to Improve the Treatment Landscape | DelveInsight The...
Tetanus Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight
November 06, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Tetanus Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight Tetanus is a serious bacterial infection caused by Clostridium...
Global Alopecia Treatment Market is Anticipated to Surpass ~USD 4 Billion by 2030 | DelveInsight
November 05, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Global Alopecia Treatment Market is Anticipated to Surpass ~USD 4 Billion by 2030 | DelveInsight The growing demand for alopecia treatments is...
Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight
November 04, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight The rising prevalence of urticaria...